Compounds > tazarotene
Page last updated: 2024-08-16

tazarotene and clindamycin

tazarotene has been researched along with clindamycin in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's2 (20.00)24.3611
2020's3 (30.00)2.80

Authors

AuthorsStudies
Draelos, ZD; Tanghetti, EA1
Shalita, A1
Abramovits, W; Loven, K; Shalita, A; Solomon, B; Tanghetti, E1
Bikowski, J; Callender, VD; Del Rosso, JQ; Draelos, ZD; Tanghetti, E1
Dhawan, S; Kircik, L; Tanghetti, E; Torok, H1
Dhawan, SS; Gwazdauskas, J1
Ashique Rahman, MA; Hota, D; Maiti, R; Parida, S; Sirka, CS; Srinivasan, A1
Guo, C; Huang, J; Li, L; Wang, XM; Yang, GP; Yang, S; Yang, XY; Ye, L; Zhang, XF1
Hang, TJ; Hu, ZL; Lu, YT; Shao, FX; Song, M1
Khattab, A; Nattouf, A1

Trials

7 trial(s) available for tazarotene and clindamycin

ArticleYear
Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy.
    Cutis, 2002, Volume: 69, Issue:2 Suppl

    Topics: Acne Vulgaris; Administration, Cutaneous; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; California; Child; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Erythromycin; Facial Dermatoses; Female; Gels; Humans; Male; Nicotinic Acids; North Carolina; Severity of Illness Index; Treatment Outcome

2002
Topical tazarotene: The BEST (balancing efficacy, speed, and tolerability) in acne trial.
    Cutis, 2004, Volume: 74, Issue:4 Suppl

    Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Face; Female; Gels; Humans; Male; Nicotinic Acids; Retinoids; Risk Factors; Time Factors; Treatment Outcome; United States

2004
Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
    Journal of drugs in dermatology : JDD, 2006, Volume: 5, Issue:3

    Topics: Acne Vulgaris; Administration, Cutaneous; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Emollients; Female; Humans; Male; Nicotinic Acids; Severity of Illness Index; Treatment Outcome; United States

2006
Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Dermatology online journal, 2007, Jul-13, Volume: 13, Issue:3

    Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gels; Humans; Keratolytic Agents; Male; Middle Aged; Nicotinic Acids; Ointments; Retinoids; Severity of Illness Index; Treatment Outcome; Tretinoin

2007
Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne.
    Cutis, 2013, Volume: 91, Issue:2

    Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide; Chi-Square Distribution; Child; Clindamycin; Dermatologic Agents; Drug Combinations; Face; Female; Gels; Humans; Male; Nicotinic Acids; Ointments; Quality of Life; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome

2013
Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
    Clinical drug investigation, 2017, Volume: 37, Issue:11

    Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Male; Nicotinic Acids; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Young Adult

2017
Safety, Tolerability, and Pharmacokinetics of Tazarotene Clindamycin Cream: A Single-Dose, 3-Period Crossover Study.
    Clinical pharmacology in drug development, 2021, Volume: 10, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Clindamycin; Cross-Over Studies; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Nicotinic Acids; Single-Blind Method; Young Adult

2021

Other Studies

3 other study(ies) available for tazarotene and clindamycin

ArticleYear
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
    Cutis, 2006, Volume: 78, Issue:2 Suppl 1

    Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Keratolytic Agents; Male; Minocycline; Naphthalenes; Nicotinic Acids; Retinoids; Treatment Outcome; Tretinoin

2006
Simultaneous determination of tazarotene, clindamycin phosphate and their active metabolites in Bama mini-pig skin by LC-MS/MS: Application to the development of a tazarotene/clindamycin phosphate cream.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2021, Jan-01, Volume: 1162

    Topics: Animals; Chromatography, Liquid; Clindamycin; Female; Linear Models; Male; Nicotinic Acids; Reproducibility of Results; Sensitivity and Specificity; Skin; Skin Cream; Swine; Swine, Miniature; Tandem Mass Spectrometry

2021
Microsponge based gel as a simple and valuable strategy for formulating and releasing Tazarotene in a controlled manner.
    Scientific reports, 2022, 07-06, Volume: 12, Issue:1

    Topics: Clindamycin; Drug Delivery Systems; Emulsifying Agents; Nicotinic Acids; Polymers

2022